MedSource (now Ergomed)

MedSource, now part of Ergomed, is an award-winning clinical research organization (CRO) that delivers high-quality clinical trials through strong relationships and specializes in oncology, neurology/CNS, and infectious diseases. We have participated in 795+ clinical trials globally; more than 250 of them have been in oncology. Our efforts support biopharmaceutical clients who conduct complex clinical trials in the most challenging disease states and patient populations. Our wide experience encompasses a range of therapeutic areas, product types, clinical trial phases and study designs. As trusted advisers and leaders in the industry, we know that strong relationships lead to strong results. While our services have expanded through the years, we’ve always kept our clients, employees and trial subjects a priority. With their needs in mind, we match a flexible process with transparency at every step along the way. Our goal is for our clients to return to MedSource whenever they need high-quality clinical trial support, because they know we will always act with their best interests in mind.

Website

http://www.ergomedplc.com

External link for MedSource (now Ergomed)

Industry

Pharmaceutical Manufacturing

Company size

51-200 employees

Headquarters

Houston, TX

Type

Public Company

Founded

1997

Specialties

Oncology, Infectious Disease, Transplant, CNS, Phase 1, Phase 2, Phase 3, Phase 4, project management, monitoring, regulatory, auditing, Data, Stats, Biometrics, Rare disease, Orphan drug, Neurology, data management, study start-up, and feasibility